Your browser doesn't support javascript.
Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain.
Otheo, Enrique; Rodríguez, Mario; Moraleda, Cinta; Domínguez-Rodríguez, Sara; Martín, María D; Herreros, María L; Vázquez, Carmen; Folgueira, María D; Pérez-Rivilla, Alfredo; Jensen, Julia; López, Agustín; Berzosa, Arantxa; Sanz de Santaeufemia, Francisco J; Jiménez, Ana B; Sainz, Talía; Llorente, Marta; Santos, Mar; Garrote, Elisa; Muñoz, Cristina; Sánchez, Paula; Illán, Marta; Coca, Ana; Barrios, Ana; Pacheco, Mónica; Arquero, Carmen; Gutiérrez, Lourdes; Epalza, Cristina; Rojo, Pablo; Serna-Pascual, Miquel; Mota, Inmaculada; Moreno, Santiago; Galán, Juan C; Tagarro, Alfredo.
  • Otheo E; Department of Pediatrics, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
  • Rodríguez M; Department of Microbiology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Moraleda C; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Domínguez-Rodríguez S; Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Madrid, Spain.
  • Martín MD; RITIP (Translational Research Network in Pediatric Infectious Diseases), Madrid, Spain.
  • Herreros ML; Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Vázquez C; Pediatric Research and Clinical Trials Unit (UPIC), Instituto de Investigación Sanitaria Hospital 12 de Octubre (IMAS12), Madrid, Spain.
  • Folgueira MD; Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Madrid, Spain.
  • Pérez-Rivilla A; RITIP (Translational Research Network in Pediatric Infectious Diseases), Madrid, Spain.
  • Jensen J; Pediatric Research and Clinical Trials Unit (UPIC), Instituto de Investigación Sanitaria Hospital 12 de Octubre (IMAS12), Madrid, Spain.
  • López A; Department of Microbiology, Laboratorio BR Salud, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
  • Berzosa A; Department of Pediatrics, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
  • Sanz de Santaeufemia FJ; Department of Pediatrics, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
  • Jiménez AB; Department of Microbiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (IMAS12), Madrid, Spain.
  • Sainz T; Department of Microbiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (IMAS12), Madrid, Spain.
  • Llorente M; Department of Pediatrics, Hospital Infanta Cristina , Parla, Madrid, Spain.
  • Santos M; Department of Pediatrics, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
  • Garrote E; Department of Pediatrics, Hospital Universitario de Getafe, Getafe, Madrid, Spain.
  • Muñoz C; Department of Pediatrics, Hospital Universitario Niño Jesús, Madrid, Spain.
  • Sánchez P; Department of Pediatrics, Fundación Jiménez Díaz, Madrid, Spain.
  • Illán M; RITIP (Translational Research Network in Pediatric Infectious Diseases), Madrid, Spain.
  • Coca A; Department of Pediatrics, Infectious and Tropical Diseases, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPAZ), Madrid, Spain.
  • Barrios A; Department of Pediatrics, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.
  • Pacheco M; RITIP (Translational Research Network in Pediatric Infectious Diseases), Madrid, Spain.
  • Arquero C; Pediatric Infectious Diseases Unit, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Gutiérrez L; Department of Pediatrics, Hospital Universitario Basurto, Bilbao, Vizcaya, Spain.
  • Epalza C; Department of Pediatrics, Hospital General de Villalba, Villalba, Madrid, Spain.
  • Rojo P; Pediatric Infectious Diseases, Immunology and Rheumatology Unit, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.
  • Serna-Pascual M; Department of Pediatrics, Hospital Clínico San Carlos, Madrid, Spain.
  • Mota I; Pediatric Intensive Care Unit, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Moreno S; Department of Pediatrics, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
  • Galán JC; Department of Pediatrics, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
  • Tagarro A; Department of Pediatrics, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
Pediatr Pulmonol ; 57(1): 253-263, 2022 01.
Article in English | MEDLINE | ID: covidwho-1966091
ABSTRACT

OBJECTIVES:

To describe the etiology of community-acquired pneumonia (CAP) in hospitalized children in Spain and analyze the predictors of the etiology.

HYPOTHESIS:

The different etiological groups of pediatric CAP are associated with different clinical, radiographic, and analytical data.

DESIGN:

Observational, multicenter, and prospective study. PATIENT SELECTION This study included children aged 1 month to 17 years with CAP, who were hospitalized between April 2012 and May 2019.

METHODS:

An extensive microbiological workup was performed. The clinical, radiographic, and analytical parameters were analyzed for three etiological groups.

RESULTS:

Among the 495 children included, at least one causative pathogen was identified in 262 (52.9%) pathogenic viruses in 155/262 (59.2%); atypical bacteria (AB), mainly Mycoplasma pneumonia, in 84/262 (32.1%); and typical bacteria (TyB) in 40/262 (15.3%). Consolidation was observed in 89/138 (64.5%) patients with viral CAP, 74/84 (88.1%) with CAP caused by AB, and 40/40 (100%) with CAP caused by TyB. Para-pneumonic pleural effusion (PPE) was observed in 112/495 (22.6%) patients, of which 61/112 (54.5%) presented a likely causative pathogen viruses in 12/61 (19.7%); AB in 23/61 (37.7%); and TyB in 26/61 (42.6%). Viral etiology was significantly frequent in young patients and in those with low oxygen saturation, wheezing, no consolidation, and high lymphocyte counts. CAP patients with AB as the etiological agent had a significantly longer and less serious course as compared to those with other causative pathogens.

CONCLUSIONS:

Viruses and M. pneumoniae are the main causes of pediatric CAP in Spain. Wheezing, young age, and no consolidation on radiographs are indicative of viral etiology. Viruses and AB can also cause PPE. Since only a few cases can be directly attributed to TyB, the indications for antibiotics must be carefully considered in each patient.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Mycoplasma / Viruses / Community-Acquired Infections Type of study: Cohort study / Etiology study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans Country/Region as subject: Europa Language: English Journal: Pediatr Pulmonol Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: Ppul.25721

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Mycoplasma / Viruses / Community-Acquired Infections Type of study: Cohort study / Etiology study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans Country/Region as subject: Europa Language: English Journal: Pediatr Pulmonol Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: Ppul.25721